Chronic Wound Treatment That Works in Henderson, NV

What I’d check before adding chronic wound treatment here

Henderson is a city of 250k–500k (320,189 Census). CDC PLACES (2023, crude) estimates 10.9% of adults in Henderson have diagnosed diabetes — 1.1 points below the U.S. 12% figure. Adult arthritis here is 25.8% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Keep 361 tissue, autologous PRP, and skin substitutes on different tickets. We onboard against that split — then ship.

Cash PRP and Medicare CTPs in the same hallway

• CDC PLACES (2023, crude) estimates 10.9% of adults in Henderson have diagnosed diabetes — 1.1 points below the U.S. 12% figure. Adult obesity in Henderson is 28.9% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. A CTP without offloading and serial measurements still fails JE review. Product is the last step, not the first.
• JE (Noridian Healthcare Solutions) is the contractor that will review CTP units, application frequency, and wound measurements for Nevada Part B claims. Practices that skip MAC education typically see denials before they see outcomes.
• Nevada is outside CDC's historical Diabetes Belt core, but the national 12% diabetes figure still applies as a planning baseline until a clinic uses its own payer mix. Clinics asking for regenerative inventory still have to separate HCT/P 361 homologous-use products from unapproved “stem cell” claims (FDA 21 CFR 1271).

Uninsured mix and Medicare CTPs in the same building

America’s Health Rankings (BRFSS 2024) only publishes state diabetes as a range nationally (Colorado 8.4% to West Virginia 18.4%). For Henderson we use CDC PLACES instead of interpolating a fake city rate from that range. CDC PLACES (2023, crude) estimates 10.9% of adults in Henderson have diagnosed diabetes — 1.1 points below the U.S. 12% figure.

How we’d stand this up in clinic